Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39618 DocGo Inc. (Exact Name of Registrant as Specified in Its Charter) | --- | --- | |------------------ ...

Exhibit 99.1 DocGo Announces Third Quarter 2024 Results Company Significantly Expands Operations on the West Coast to Support New Payer Programs, Increases Full-Year Guidance for Cash Flow from Operations Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time NEW YORK, NY, November 7, 2024 – DocGo Inc. (Nasdaq: DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended Septembe ...

DocGo Inc. (DCGO) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.07 per share. This compares to loss of $0.02 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -14.29%. A quarter ago, it was expected that this company would post earnings of $0.09 per share when it actually produced earnings of $0.09, delivering no surprise. Over the last four quarters, the company has not been ab ...

DocGo Announces Record Second Quarter 2023 Results August 7, 2023 at 4:05 PM EDT Company Raises 2023 Revenue Guidance To $540-$550 Million Increases Adjusted EBITDA1 Guidance To $48-$53 Million NEW YORK--(BUSINESS WIRE)--Aug. 7, 2023-- DocGo Inc. (Nasdaq: DCGO), a leading provider of last-mile mobile health services today announced financial and operating results for the quarter ended June 30, 2023. Q2 2023 Financial Highlights Total revenue for the second quarter of 2023 was $125.5 million, up from $113.0 ...

Financial Data and Key Metrics Changes - Total revenue for Q2 2024 was $164.9 million, a 31% increase from Q2 2023 [16] - Adjusted EBITDA for Q2 2024 was $17.2 million, up from $9.1 million in Q2 2023, with an adjusted EBITDA margin of 10.4% [17] - Net income for Q2 2024 was $5.9 million compared to $1.3 million in Q2 2023 [17] - GAAP gross margin percentage was 31.3%, up from 30.3% in Q2 2023, while adjusted gross margin was 33.9% compared to 33.4% in Q2 2023 [19] Business Line Data and Key Metrics Changes - Mobile Health revenue for Q2 2024 was $116.7 million, a 46% increase from Q2 2023, accounting for 71% of total revenues [16][17] - Transportation services revenue increased to $48.2 million in Q2 2024, which was 6% higher than Q2 2023 [16] - Adjusted gross margin from the Mobile Health segment was 35.9%, compared to 34.9% in Q2 2023 [20] Market Data and Key Metrics Changes - The largest revenue gains occurred in New York, Pennsylvania, and the U.K. [16] - The company is seeing strong results from care gap closure services, with a doubling of patients assigned for these services in Q2 compared to Q1 [9][10] Company Strategy and Development Direction - The company is focusing on expanding its mobile health services and has launched initiatives to engage with prospective partners across three customer verticals [6][8] - A world-class Medical Advisory Board has been established to enhance clinical offerings and publish research on patient outcomes [8] - The company is transitioning from migrant-related projects to pursue new opportunities, which is expected to enhance growth [14] Management's Comments on Operating Environment and Future Outlook - Management expects continued strong cash flow from operations, increasing guidance from $70 million to $80 million to a new range of $80 million to $90 million for 2024 [8][26] - The company anticipates a decline in migrant-related revenues but expects to benefit from improved cash collections and operational efficiencies [25][26] - Management is optimistic about the growth potential in the mobile health sector, particularly in care gap closures and primary care offerings [32][41] Other Important Information - The company repurchased approximately $5 million worth of shares during the period and nearly $10 million since the start of 2024 [7][25] - Cash flow from operations exceeded $35 million in Q2 2024, driving up cash balance by more than $25 million relative to Q1 [7][22] Q&A Session Summary Question: What is driving the recent contract wins? - Management indicated that both market adoption for in-home care and the ROI of their programs are contributing factors [27][28] Question: Did the core business grow 30% year-over-year? - The core business was relatively flat quarter-over-quarter, but management anticipates growth in the second half of the year [29][30] Question: What are the revenue expectations for fiscal 2025? - The base business is expected to be $400 million, with additional revenues potentially from migrant-related services [34][35] Question: How does the company fit into the current healthcare environment? - Management believes their proactive care model aligns well with rising healthcare costs and aims to reduce hospital readmissions [39][40] Question: What is the outlook for cash flow conversion? - Management expects a typical conversion of about $30 million in cash flow from the projected $40 million EBITDA [46][49]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39618 DocGo Inc. (Exact Name of Registrant as Specified in Its Charter) | --- | --- | |----------------------- ...

Exhibit 99.1 DocGo Announces Strong Second Quarter 2024 Results Company Raises Cash Flow From Operations Guidance to $80-$90 Million, Reiterates 2024 Revenue Guidance of $600-$650 Million and Adjusted EBITDA Guidance of $65-$75 Million 1 Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time (Note Corrected Call Information Below) NEW YORK, NY, August 7, 2024 – DocGo Inc. (Nasdaq: DCGO) ("DocGo" or the "Company"), a leading provider of technologyenabled mobile health services, today an ...

DocGo Inc. (NASDAQ:DCGO) Q1 2024 Earnings Conference Call May 8, 2024 5:00 PM ET Company Participants Mike Cole - Director, Investor Relations Lee Bienstock - Chief Executive Officer Norman Rosenberg - Chief Financial Officer Conference Call Participants Ryan MacDonald - Needham Richard Close - Canaccord Genuity David Larsen - BTIG Kieran Ryan - Deutsche Bank Sarah James - Cantor Fitzgerald David Grossman - Stifel Operator Greetings and welcome to the DocGo First Quarter 2024 Earnings Conference Call. [Oper ...

DocGo Inc. (DCGO) came out with quarterly earnings of $0.09 per share, in line with the Zacks Consensus Estimate. This compares to loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this company would post earnings of $0.13 per share when it actually produced earnings of $0.06, delivering a surprise of -53.85%.Over the last four quarters, the company has not been able to surpass consensus EPS estimates.Motion Acquisition, which belongs ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to DocGo Inc. (Exact Name of Registrant as Specified in Its Charter) | Delaware | 85-2515483 | | --- | --- | | (State or Other Jurisdiction ...